Princeton Innovations is a leading supplier to the pharmaceutical industry, offering a wide range of specialised services aimed at supporting drug development and manufacturing processes. The company focuses on delivering innovative solutions, ensuring compliance with industry standards and enhancing the efficiency of pharmaceutical projects. Princeton Innovations employs advanced methodologies in their operations, thereby fostering success for their clients and promoting advancements in pharmaceutical innovation.

Services include:
– 505(b)(2)
– Accelerated Stability Studies
– Analytical Services
– API Solubilization Technologies
– Contract Development and Manufacturing (CDMO)
– Contract Research (CRO)
– Drug Delivery Devices
– Process Development
– Formulation Development
– Manufacturing
– Tablets
– Particle Size Analysis
– Preformulation
– Stability
– ICH

Princeton Innovations continues to establish itself as a vital partner in the pharmaceutical industry, emphasising quality and innovation in all their undertakings. To learn more about their comprehensive offerings, please visit pigenerics.com.